Total Payments
$26,880
2024 Payments
$440.45
Companies
13
Transactions
114
Medicare Patients
619
Medicare Billing
$67,947
Payment Breakdown by Category
Other$22,839 (85.0%)
Food & Beverage$2,307 (8.6%)
Travel$1,635 (6.1%)
Education$99.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,839 | 18 | 85.0% |
| Food and Beverage | $2,307 | 85 | 8.6% |
| Travel and Lodging | $1,635 | 10 | 6.1% |
| Education | $99.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $9,314 | 18 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $8,458 | 28 | $0 (2024) |
| ABBVIE INC. | $7,956 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $730.81 | 24 | $0 (2024) |
| Lundbeck LLC | $144.20 | 7 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $96.53 | 1 | $0 (2019) |
| Indivior Inc. | $44.67 | 2 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $37.21 | 2 | $0 (2024) |
| Corium, LLC | $24.57 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $22.62 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $440.45 | 21 | ABBVIE INC. ($99.92) |
| 2023 | $1,403 | 17 | AbbVie Inc. ($1,156) |
| 2022 | $2,721 | 9 | ABBVIE INC. ($2,705) |
| 2021 | $3,995 | 7 | AbbVie Inc. ($3,995) |
| 2020 | $86.33 | 1 | Janssen Pharmaceuticals, Inc ($86.33) |
| 2019 | $9,600 | 20 | Allergan Inc. ($9,175) |
| 2018 | $8,591 | 36 | Otsuka America Pharmaceutical, Inc. ($8,001) |
| 2017 | $41.77 | 3 | Lundbeck LLC ($16.31) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.96 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.06 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.49 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $20.23 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Neuropsychiatry | ||||||
| 07/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Central Nervous System | ||||||
| 06/18/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: BH | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: BH | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: PSYCHIATRY | ||||||
| 02/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Neuroscience | ||||||
| 02/06/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.54 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/15/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 127 | 372 | $62,029 | $16,809 |
| 2022 | 3 | 121 | 447 | $74,314 | $19,546 |
| 2021 | 4 | 115 | 372 | $61,962 | $17,212 |
| 2020 | 6 | 256 | 537 | $68,416 | $14,380 |
Total Patients
619
Total Services
1,728
Medicare Billing
$67,947
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 183 | $38,609 | $12,229 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 42 | $5,951 | $2,224 | 37.4% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 40 | 109 | $16,466 | $2,078 | 12.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 38 | $1,002 | $277.23 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 234 | $49,369 | $16,026 | 32.5% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 49 | 155 | $23,414 | $2,978 | 12.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 58 | $1,530 | $541.53 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 189 | $39,875 | $14,061 | 35.3% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 44 | 134 | $20,242 | $2,700 | 13.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 11 | 23 | $957.58 | $230.54 | 24.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 26 | $887.48 | $220.80 | 24.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 73 | 229 | $32,686 | $7,824 | 23.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 64 | 133 | $20,091 | $2,250 | 11.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 39 | $8,228 | $2,125 | 25.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 32 | 41 | $3,505 | $1,147 | 32.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 38 | 59 | $2,472 | $874.87 | 35.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 16 | 36 | $1,434 | $158.89 | 11.1% |
About Dr. Patrick Young, MD
Dr. Patrick Young, MD is a Psychosomatic Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508082652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Young, MD has received a total of $26,880 in payments from pharmaceutical and medical device companies, with $440.45 received in 2024. These payments were reported across 114 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,839).
As a Medicare-enrolled provider, Young has provided services to 619 Medicare beneficiaries, totaling 1,728 services with total Medicare billing of $67,947. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychosomatic Medicine
- Other Specialties Child & Adolescent Psychiatry, Psychiatry
- Location Dallas, TX
- Active Since 04/17/2007
- Last Updated 10/24/2023
- Taxonomy Code 2084P0015X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508082652
Products in Payments
- VRAYLAR (Drug) $17,270
- ABILIFY MAINTENA (Drug) $8,510
- INVEGA TRINZA (Drug) $434.60
- INVEGA SUSTENNA (Drug) $296.21
- REXULTI (Drug) $188.13
- PERSERIS (Drug) $44.67
- INGREZZA (Drug) $37.21
- Azstarys (Drug) $24.57
- Austedo XR (Drug) $22.62
- JORNAY PM (Drug) $18.96
- CAPLYTA (Drug) $16.38
- LATUDA (Drug) $15.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychosomatic Medicine Doctors in Dallas
Dr. Kathryn Ortiz, M.d, M.D
Psychosomatic Medicine — Payments: $117.70
Psychosomatic Medicine $117.70
Mr. Jonathan Devries, D.o, D.O
Psychosomatic Medicine — Payments: $89.89
Psychosomatic Medicine $89.89
Dr. Michael Rafferty, M.d, M.D
Psychosomatic Medicine — Payments: $10.77
Psychosomatic Medicine $10.77